Thursday, February 26, 2009

Bedford Laboratories to Begin Shipping Sumatriptan Succinate Injection

Bedford Laboratories, a division of Ben Venue Laboratories, Inc., today announced the launch of Sumatriptan Succinate Injection. This product is AP rated and is equivalent to Imitrex(R) by GlaxoSmithKline.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)